brryh, just for this purpose on the 23rd of June I sent a long letter to Kempler via Rebecca Wilson, and Rebecca told me "Well received and I understand your frustration. Leve this for me to work through. Confirming the note will be shared with Geoffrey and actioned".
It is now 3 weeks and nothing yet. You would think that are worried about the market value and share price, but Stamler is talking about only one molecule, ATH434, and not at all about PBT2 with much more potential than ATH434.
something is going on for pbt2, page-5
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $23.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.603K | 341.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 68910222 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 29034580 | 23 |
View Market Depth
| Last trade - 15.59pm 04/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |